title: Heparin-induced thrombocytopenia and paradoxical venous thromboses.
authors.affiliation: General Intensive Care Unit, Beilinson Medical Center, Petah Tikva, Israel.
authors.forename: E S
authors.initials: ES
authors.lastname: Grozovski
authors.forename: J D
authors.initials: JD
authors.lastname: Cohen
authors.forename: G
authors.initials: G
authors.lastname: Grunberg
authors.forename: J
authors.initials: J
authors.lastname: Keslin
authors.forename: S
authors.initials: S
authors.lastname: Gassner
mesh_terms: D000368:Aged; D001367:Axillary Vein; D003327:Coronary Disease / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D005268:Femoral Vein; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000150:complications; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D010976:Platelet Count; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000150:complications; D013927:Thrombosis / Q000139:chemically induced* / Q000150:complications
chemical_list: D017984:Enoxaparin; D006493:Heparin